{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:45:56Z","timestamp":1782956756261,"version":"3.54.5"},"reference-count":72,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["394046635"],"award-info":[{"award-number":["394046635"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["421152132"],"award-info":[{"award-number":["421152132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","award":["01 GM 0310"],"award-info":[{"award-number":["01 GM 0310"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Scleroderma renal crisis (SRC) is an acute life-threatening manifestation of systemic sclerosis (SSc) caused by obliterative vasculopathy and thrombotic microangiopathy. Evidence suggests a pathogenic role of immunoglobulin G (IgG) targeting G-protein coupled receptors (GPCR). We therefore dissected SRC-associated vascular obliteration and investigated the specific effects of patient-derived IgG directed against angiotensin II type 1 (AT1R) and endothelin-1 type A receptors (ETAR) on downstream signaling events and endothelial cell proliferation. SRC-IgG triggered endothelial cell proliferation via activation of the mitogen-activated protein kinase (MAPK) pathway and subsequent activation of the E26 transformation-specific-1 transcription factor (Ets-1). Either AT1R or ETAR receptor inhibitors\/shRNA abrogated endothelial proliferation, confirming receptor activation and Ets-1 signaling involvement. Binding of Ets-1 to the tissue factor (TF) promoter exclusively induced TF. In addition, TF inhibition prevented endothelial cell proliferation. Thus, our data revealed a thus far unknown link between SRC-IgG-induced intracellular signaling, endothelial cell proliferation and active coagulation in the context of obliterative vasculopathy and SRC. Patients\u2019 autoantibodies and their molecular effectors represent new therapeutic targets to address severe vascular complications in SSc.<\/jats:p>","DOI":"10.3390\/ijms23010244","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T01:18:15Z","timestamp":1640654295000},"page":"244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-7860","authenticated-orcid":false,"given":"Rusan","family":"Catar","sequence":"first","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Herse-Naether","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4710-4571","authenticated-orcid":false,"given":"Nan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Wischnewski","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Kusch","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Berlin Institute of Health, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kamhieh-Milz","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Eisenreich","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Rauch","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hegner","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Vitanas Klinik f\u00fcr Geriatrie, 13435 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[{"name":"CellTrend GmbH, 14943 Luckenwalde, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kill","sequence":"additional","affiliation":[{"name":"Deutsches Rheuma-Forschungszentrum (DRFZ), A. Leibniz Institute, 10117 Berlin, Germany"},{"name":"Department of Rheumatology and Clinical Immunology, CCM, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[{"name":"Deutsches Rheuma-Forschungszentrum (DRFZ), A. Leibniz Institute, 10117 Berlin, Germany"},{"name":"Department of Rheumatology and Clinical Immunology, CCM, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Priority Area Asthma & Allergy, Research Center Borstel, Airway Research Center North (ARCN), Members of the German Center for Lung Research (DZL), 23845 Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Kleinau","sequence":"additional","affiliation":[{"name":"Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-2075","authenticated-orcid":false,"given":"Patrick","family":"Scheerer","sequence":"additional","affiliation":[{"name":"Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"DZHK (Deutsches Zentrum f\u00fcr Herz-Kreislauf Forschung), Partner Site Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duska","family":"Dragun","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Berlin Institute of Health, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-9763","authenticated-orcid":false,"given":"Aurelie","family":"Philippe","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Center for Cardiovascular Research, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"},{"name":"Berlin Institute of Health, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine"},{"key":"ref_3","first-page":"543704","article-title":"Scleroderma renal crisis: A pathology perspective","volume":"2010","author":"Batal","year":"2010","journal-title":"Int. J. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature08144","article-title":"The structure and function of G-protein-coupled receptors","volume":"459","author":"Rosenbaum","year":"2009","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Marques","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/HYPERTENSIONAHA.112.197871","article-title":"Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II","volume":"60","author":"Feng","year":"2012","journal-title":"Hypertension"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"C472","DOI":"10.1152\/ajpcell.1998.274.2.C472","article-title":"Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells","volume":"274","author":"Naito","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F1094","DOI":"10.1152\/ajprenal.00458.2007","article-title":"Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells","volume":"294","author":"Pearse","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1172\/JCI24403","article-title":"Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling","volume":"115","author":"Zhan","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.autrev.2011.01.007","article-title":"The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus","volume":"10","author":"Leng","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00109-001-0316-0","article-title":"The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis","volume":"80","author":"Wernert","year":"2002","journal-title":"J. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.RES.0000251056.85990.db","article-title":"Regulation of vascular inflammation and remodeling by ETS factors","volume":"99","author":"Oettgen","year":"2006","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/REP-07-0374","article-title":"Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells","volume":"136","author":"Herr","year":"2008","journal-title":"Reproduction"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH09-02-0128","article-title":"Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae","volume":"102","author":"Kern","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1681\/ASN.V96969","article-title":"Effects of angiotensin II on endothelial cell growth: Role of AT-1 and AT-2 receptors","volume":"9","author":"Monton","year":"1998","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2009-03-211391","article-title":"Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis","volume":"114","author":"Wei","year":"2009","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2012.04848.x","article-title":"Tissue factor-Akt signaling triggers microvessel formation","volume":"10","author":"Arderiu","year":"2012","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10456-012-9293-x","article-title":"Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization","volume":"15","author":"Arderiu","year":"2012","journal-title":"Angiogenesis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II-mediated microvascular thrombosis","volume":"56","author":"Senchenkova","year":"2010","journal-title":"Hypertension"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.131210","article-title":"Scleroderma renal crisis","volume":"41","author":"Mouthon","year":"2014","journal-title":"J. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: Patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_31","first-page":"98","article-title":"Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis","volume":"35","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1002\/jcb.27631","article-title":"Endothelin-1 triggers human peritoneal mesothelial cells\u2019 proliferation via ERK1\/2-Ets-1 signaling pathway and contributes to endothelial cell angiogenesis","volume":"120","author":"Zhu","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63741-8","article-title":"Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization","volume":"164","author":"Watanabe","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2013040424","article-title":"The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula","volume":"25","author":"Feng","year":"2014","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1749-6632.2009.04632.x","article-title":"In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes","volume":"1173","author":"Clemens","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0961203310361489","article-title":"Antiphospholipid syndrome treatment beyond anticoagulation: Are we there yet?","volume":"19","author":"Pierangeli","year":"2010","journal-title":"Lupus"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1523-1755.2001.060002722.x","article-title":"Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin II type 1a receptor null mutant mice","volume":"60","author":"Inokuchi","year":"2001","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1369\/jhc.5A6888.2006","article-title":"Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney","volume":"54","author":"Wendel","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1093\/rheumatology\/ken481","article-title":"Overview of pathogenesis of systemic sclerosis","volume":"48","author":"Abraham","year":"2009","journal-title":"Rheumatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/cvr\/cvaa164","article-title":"Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats","volume":"117","author":"Cheng","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, K., Kan, H., Mao, A., Geng, L., and Ma, X. (2021). Single-cell analysis of salt-induced hypertensive mouse aortae reveals cellular heterogeneity and state changes. Exp. Mol. Med.","DOI":"10.1038\/s12276-021-00704-w"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/annrheumdis-2021-220209","article-title":"Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis","volume":"80","author":"Gaydosik","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3389\/fimmu.2018.02191","article-title":"Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin","volume":"9","author":"Apostolidis","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dixon, E., Wu, H., Muto, Y., Wilson, P., and Humphreys, B. (2021). Spatially Resolved Transcriptomic Analysis of Acute Kidney Injury in a Female Murine Model. J. Am. Soc. Nephrol. JASN.","DOI":"10.1681\/ASN.2021081150"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1159\/000366321","article-title":"Ets-1 targeted by microrna-221 regulates angiotensin II-induced renal fibroblast activation and fibrosis","volume":"34","author":"Di","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"ref_49","first-page":"10216","article-title":"Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis","volume":"8","author":"Hao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2019.52.10.206","article-title":"Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition","volume":"52","author":"Xu","year":"2019","journal-title":"BMB Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"560170","DOI":"10.3389\/fphys.2020.560170","article-title":"Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bjp.0706193","article-title":"Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: Role of ETB receptor, NADPH oxidase and caveolin-1","volume":"145","author":"Dong","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_53","first-page":"H686","article-title":"Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors","volume":"269","author":"Morbidelli","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64807-9","article-title":"Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"157","author":"Salani","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.thromres.2005.04.033","article-title":"Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes","volume":"117","author":"He","year":"2006","journal-title":"Thromb. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0002-9440(10)64523-3","article-title":"Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy","volume":"157","author":"Muller","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4049\/jimmunol.1003756","article-title":"Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade","volume":"186","author":"Kambas","year":"2011","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","article-title":"AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor","volume":"101","author":"Dechend","year":"2000","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.rhu.0000173220.45196.75","article-title":"Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker","volume":"11","author":"Rajendran","year":"2005","journal-title":"J. Clin. Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis","volume":"22","author":"Butikofer","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2021.01.022","article-title":"Prediction and primary prevention of major vascular complications in systemic sclerosis","volume":"87","author":"Bruni","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3899\/jrheum.180582","article-title":"Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication","volume":"47","author":"Moinzadeh","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2186","article-title":"How does endothelial cell injury start? The role of endothelin in systemic sclerosis","volume":"9","author":"Abraham","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Yang, Y., Kim, H.J., Woo, K.J., Cho, D., and Bang, S.I. (2017). Lipo-PGE1 suppresses collagen production in human dermal fibroblasts via the ERK\/Ets-1 signaling pathway. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179614"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/art.24935","article-title":"Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts","volume":"60","author":"Bogatkevich","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","article-title":"Therapy of scleroderma renal crisis: State of the art","volume":"17","author":"Zanatta","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-62703-493-7_19","article-title":"The detection of antibodies to the Angiotensin II-type 1 receptor in transplantation","volume":"1034","author":"Dragun","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvp117","article-title":"The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1","volume":"83","author":"Kusch","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1755-5922.2011.00305.x","article-title":"Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells","volume":"31","author":"Pepke","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2010.07.047","article-title":"Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration","volume":"213","author":"Breyne","year":"2010","journal-title":"Atherosclerosis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:54:08Z","timestamp":1760169248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23010244"],"URL":"https:\/\/doi.org\/10.3390\/ijms23010244","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,27]]}}}